Jane Street Group, LLC Altimmune, Inc. Transaction History

Jane Street Group, LLC

$616 Billion
Q3 2025

A detailed history of Jane Street Group, LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 280,199 shares of ALT stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

280,199

Previous 95,400 193.71%

Holding current value

$1.17 Million

Previous $369,000 186.18%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$3.38 - $4.76 $947,072 - $1.33 Million	280,199 New	280,199 $1.06 Million
Q1 2025 May 14, 2025	SELL	$5.0 - $7.45 $630,040 - $938,759	-126,008 Reduced 45.22%	152,642 $763,000
Q4 2024 Feb 14, 2025	SELL	$6.02 - $9.85 $626,158 - $1.02 Million	-104,013 Reduced 27.18%	278,650 $2.01 Million
Q3 2024 Nov 14, 2024	BUY	$5.5 - $8.1 $1.36 Million - $2 Million	246,412 Added 180.85%	382,663 $2.35 Million
Q2 2024 Aug 14, 2024	BUY	$5.91 - $10.23 $204,923 - $354,715	34,674 Added 34.14%	136,251 $906,000

Q1 2024 May 15, 2024	SELL	$8.22 - $13.81 $3.94 Million - $6.61 Million	-478,867 Reduced 82.5%	101,577 $1.03 Million
Q4 2023 Feb 14, 2024	BUY	$2.14 - $11.62 $1.12 Million - $6.06 Million	521,495 Added 884.65%	580,444 $6.53 Million
Q3 2023 Nov 14, 2023	SELL	$2.4 - $3.45 $555,184 - $798,078	-231,327 Reduced 79.69%	58,949 $153,000
Q2 2023 Aug 14, 2023	BUY	$3.45 - $5.97 $370,947 - $641,900	107,521 Added 58.83%	290,276 $1.02 Million
Q1 2023 May 15, 2023	SELL	$4.19 - $16.83 $261,405 - $1.05 Million	-62,388 Reduced 25.45%	182,755 $771,000
Q4 2022 Feb 14, 2023	BUY	$8.74 - $16.45 $127,429 - $239,841	14,580 Added 6.32%	245,143 $4.03 Million
Q3 2022 Nov 14, 2022	BUY	$10.67 - $22.41 $1.99 Million - $4.18 Million	186,349 Added 421.47%	230,563 $2.94 Million
Q2 2022 Aug 16, 2022	SELL	$3.94 - $11.77 $9,928 - $29,660	-2,520 Reduced 5.39%	44,214 $517,000
Q1 2022 May 17, 2022	BUY	$5.9 - $9.45 $51,212 - $82,026	8,680 Added 22.81%	46,734 $285,000
Q4 2021 Feb 15, 2022	BUY	$8.69 - $12.48 $141,968 - $203,885	16,337 Added 75.23%	38,054 $349,000
Q3 2021 Nov 16, 2021	SELL	$8.43 - $16.81 $1.37 Million - $2.74 Million	-163,087 Reduced 88.25%	21,717 $245,000
Q2 2021 Aug 16, 2021	BUY	$9.85 - $16.46 $894,133 - $1.49 Million	90,775 Added 96.54%	184,804 $1.82 Million
Q1 2021 May 18, 2021	BUY	$12.71 - $24.31 $803,322 - $1.54 Million	63,204 Added 205.04%	94,029 $1.33 Million
Q4 2020 Feb 17, 2021	BUY	$7.84 - $14.22 $241,668 - $438,331	30,825 New	30,825 $348,000
Q1 2019 May 16, 2019	SELL	$2.54 - $4.54 $26,164 - $46,766	-10,301 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$1.72 - $7.24 $17,717 - $74,579	10,301 New	10,301 $21,000

Others Institutions Holding ALT

# of Institutions

195

Shares Held

40.1M

Call Options Held

3.82M

Put Options Held

2.8M

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $204M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Altimmune, Inc. Transaction History